SYMPATH Symposium // Event

Project description:

The “SYMPATH Symposium on Targeting Synucleinopathies” took place on 28th March 2017 at the Research Institute of Molecular Pathology (IMP) situated at the Vienna Biocenter, Austria. The symposium presented the results of the SYMPATH project in the context of a high-profile scientific meeting that brought together world-leading experts to discuss recent progress in developing new potential biomarkers and therapeutic concepts, including vaccines, for Parkinson´s disease (PD) and multiple system atrophy (MSA).

The SYMPATH symposium was the result of close cooperation in the planning, organisation and implementation between SYMPATH partners biolution, AFFiRiS and a symposium organising committee composed of Dr Gergana Galabova (AFF), Dr Günther Staffler (AFF) and Prof. Wassilios Meissner (CHUB).

It was important aim of the SYMPATH symposium organisers to complement the world-class research taking place within the SYMPATH project with a broad selection of world-leading external speakers.

 

Kuldip Dave, Michael J. Fox Foundation, USA
Joaquim Ferreira, University of Lisbon, Portugal
Gergana Galabova, AFFiRiS, Austria
Nour Majbour, Hamid Bin Khalifa University, Qatar
Kenneth Marek, Yale University, USA
Eliezer Masliah, National Institute on Aging at NIH, USA
Wassilios Meissner, University Hospital Bordeaux, France
Werner Poewe, Medical University Innsbruck, Austria
Dieter Volc, Prosenex, Austria
Dieter Willbold, Forschungszentrum Jülich, Germany

 

Photo
 

In addition to the scientific presentations the SYMPATH symposium also hosted a poster session featuring all scientific WPs of the SYMPATH project and an interactive exhibition, which attracted additional interest not just from symposium attendees but also researchers from the Vienna Biocenter. The symposium exhibition also doubled as the launch event for the SYMPATH video.

The SYMPATH symposium was a great success, bringing together an excellent selection of world-leading experts and attracting 115 attendees. Highly positive feedback was received from many of the speakers and symposium attendees crediting the excellent range of speakers, the good organisation and the positive environment for discussion and scientific exchange.

Quick overview:

Funding: FP7-HEALTH through SYMPATH (602999)
Coordinator: AFFiRiS AG, Austria
Status: Completed
Date: 28.03.2017
Location: Vienna-Austria

 
PROJECT WEBSITE

biolution contribution:

Concept, Co-organisation of the event, Communication measures

Partners / Supporters
AFFiRiS AG, AT
biolution GmbH, AT
Medical University Bordeaux, FRA
Research Institute of Molecular Pathology, AT
neu marx, AT
Vienna Biocenter, AT

affiris_logo.jpg
jbiolution_logo.jpg




Clinical Trials Events FP7 ND Sympath Vaccines

Related items: